| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 40.33▲ | 40.02▲ | 39.85▲ | 34.44▲ | 35.76▲ |
| MA10 | 40.22▲ | 39.63▲ | 37.85▲ | 33.96▲ | 34.99▲ |
| MA20 | 40.01▲ | 37.47▲ | 35.72▲ | 34.87▲ | 36.56▲ |
| MA50 | 39.65▲ | 34.73▲ | 33.76▲ | 34.58▲ | N/A |
| MA100 | 38.09▲ | 33.75▲ | 34.44▲ | 36.25▲ | N/A |
| MA200 | 35.87▲ | 34.57▲ | 34.96▲ | 39.53▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.021▲ | 0.155▲ | 0.620▲ | 0.311▲ | 0.484▲ |
| RSI | 66.707▲ | 87.611▲ | 89.077▲ | 73.176▲ | 55.376▲ |
| STOCH | 83.558▲ | 94.123▲ | 96.900▲ | 41.030 | 60.259 |
| WILL %R | -29.778 | -4.952▲ | -4.295▲ | -4.772▲ | -16.967▲ |
| CCI | 102.236▲ | 103.071▲ | 92.591 | 226.673▲ | 155.468▲ |
| ▲ RSI&STOCH | $MDLN Overbought RSI + Stochastic | Set Alert |
| ▲ RSI&MACD | $MDLN MACD cross and RSI above 55 | Set Alert |
| ▲ RSI&VOL | $MDLN RSI Cross Up and Volume | Set Alert |
| ▲ RSI | $MDLN RSI(14) Crossed Above 70 | Set Alert |
| RSI | $MDLN RSI(14) Crossed Above 50 | Set Alert |
| ▲ MACD | $MDLN MACD(12,26,9) Crossed Above Zero | Set Alert |
| ▲ MACD | $MDLN MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| MA | $MDLN Price Crossed Above MA(200) | Set Alert |
| MA | $MDLN Price Crossed Above MA(50) | Set Alert |
| MA | $MDLN Price Crossed Above MA(26) | Set Alert |
| ▲ GAP | $MDLN Open Gap Up %5 | Set Alert |
| ▲ GAP | $MDLN Open Gap Up %3 | Set Alert |
| ▲ GAP | $MDLN Open Gap Up %2 | Set Alert |
| ▲ BREAK | $MDLN Price Breaks 60 Days High | Set Alert |
| ▲ BREAK | $MDLN Price Breaks 30 Days High | Set Alert |
| ▲ BREAK | $MDLN Price Breaks 20 Days High | Set Alert |
| ▲ BREAK | $MDLN Price Breaks 10 Days High | Set Alert |
|
Wednesday, November 04, 2026 01:20 PM
Key TakeawaysMedline shares jumped 18% after a third-quarter beat, a raised sales outlook and a $1 billion buyback. Organic sales grew 10.
|
|
Wednesday, November 04, 2026 09:40 AM
As Medline expects continued net sales growth in 2027, it also plans to implement a prince increase to offset inflation pressures.
|
|
Wednesday, November 04, 2026 06:10 AM
Looking ahead, Medline reaffirmed its fiscal 2026 Adjusted EBITDA guidance of $3.3 billion - $3.4 billion. In the pre-market activity on Wednesday, Medline shares were gaining 8.54 percent and trading ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/11/26 | 37.37 | 40.80 | 37.06 | 40.35 | 25,468,437 |
| 03/11/26 | 33.70 | 34.26 | 32.92 | 34.09 | 14,611,994 |
| 02/11/26 | 32.34 | 33.90 | 32.26 | 33.63 | 8,276,997 |
| 30/10/26 | 31.93 | 32.32 | 31.37 | 32.12 | 14,555,835 |
| 29/10/26 | 32.805 | 33.40 | 31.87 | 32.00 | 15,889,134 |
| 28/10/26 | 32.13 | 32.72 | 32.061 | 32.37 | 8,515,390 |
| 27/10/26 | 33.75 | 33.855 | 32.35 | 32.38 | 10,645,192 |
| 26/10/26 | 34.09 | 34.25 | 33.30 | 33.69 | 8,129,190 |
| 23/10/26 | 34.66 | 35.015 | 33.77 | 34.09 | 7,439,601 |
| 22/10/26 | 34.85 | 35.03 | 33.63 | 34.88 | 14,946,479 |
|
|
||||
|
|
||||
|
|